Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications

Table of Contents

Block I Tools, Toolstations and Models 1. Germ-Free Animals as a Tool to Study Indigenous Microbiota 2. Germ-Free Mouse Technology in Cardiovascular Research 3. The Gut Microbiome Beyond the BacteriomedThe Neglected Role of Virome and Mycobiome in Health and Disease 4. Techniques for Phenotyping the Gut Microbiota Metabolome 5. Metabolomics Tools and Information Retrieval in Microbiome Hacking 6. Laboratory Simulators of the Colon Microbiome 7. Potential of Metabolomics to Breath Tests

Block II Background Information 8. Metabolome and Microbiome From Infancy to Elderly 9. The Oral Microbiome 10. The Gastric Microbiome in Benign and Malignant Diseases 11. The Human Vaginal Microbiome 12. Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine 13. Role of the Microbiome in Intestinal Barrier Function and Immune Defense 14. The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric Surgery

Block III Established and Experimental Interventions 15. Use of Probiotics in In?ammatory Bowel Disease 16. Current Status of Fecal Microbiota Transplantation 17. Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials 18. Current Options for Fecal Transplantation in Clostridium dif?cile Infection 19. Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy 20. The Unknown Effect of AntibioticInduced Dysbiosis on the Gut Microbiota 21. The Myth and Therapeutic Potentials of Postbiotics

Block IV Diagnostic and Therapeutical Applications 22. The Microbiome and Metabolome in Metabolic Syndrome 23. The Gut Microbiota as a Therapeutic Approach for Obesity 24. The Gut Microbiome After Bariatric Surgery 25. Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management 26. The Emerging Role of MicrobiomeeGuteBrain Axis in Functional Gastrointestinal Disorders 27. The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease 28. The Microbiome and Metabolome in Alcoholic Liver Disease 29. The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis 30. Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis? 31. The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease

Authors

Joel Faintuch Senior Professor, Department of Gastroenterology, Sao Paulo University Medical School, Sao Paulo, Brazil. Joel Faintuch is a gastrointestinal surgeon, and former International Guest Fellow of the American College of Surgeons. He is Honorary Fellow of three Surgical Societies, and has served as Visiting Professor at the University of Maastricht. He was the pioneer of Parenteral and Enteral Nutrition in Brazil and South America, and a founding member of three medical societies. In the last years, his focus has been in the Intestinal Microbiome. Joel Faintuch is the author of over 250 articles in peer-reviewed journals, along with 10 books, three theses, and over 200 chapters in books, and other publications. Salomao Faintuch Clinical Director of Vascular and Interventional Radiology, Co-Director, Advanced Vascular Care Center, Assistant Professor of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts, USA. Salomao Faintuch is the Clinical Director of Vascular and Interventional Radiology at Beth Israel Deaconess Medical Center and Harvard Medical School. He has authored more than 50 articles in peer-reviewed journals, along with 5 Society Guidelines and Standards of Practice and 3 textbooks. He is a Radiological Society of North America Research Scholar, serves in eight national society committees, and is member of the Editorial Board of three international journals.